MEP36708A - Solutions containing epinastine - Google Patents

Solutions containing epinastine

Info

Publication number: MEP36708A
Authority: ME; Montenegro
Prior art keywords: solutions containing; containing epinastine; optionally; epinastine; racemate
Prior art date: 1999-11-12

Application number

MEP-367/08A

Other languages

Bosnian (bs)

English (en)

Inventor

Volker Trach

Gerold Duschler

Original Assignee

Boehringer Ingelheim Int

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-11-12

Filing date

2000-10-14

Publication date

2011-02-10

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7928843&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MEP36708(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2000-10-14 Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int

2011-02-10 Publication of MEP36708A publication Critical patent/MEP36708A/xx

Links

WHWZLSFABNNENI-UHFFFAOYSA-N epinastine Chemical compound C1C2=CC=CC=C2C2CN=C(N)N2C2=CC=CC=C21 WHWZLSFABNNENI-UHFFFAOYSA-N 0.000 title abstract 2
229960003449 epinastine Drugs 0.000 title abstract 2
HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 abstract 1
239000002253 acid Substances 0.000 abstract 1
239000007864 aqueous solution Substances 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F01—MACHINES OR ENGINES IN GENERAL; ENGINE PLANTS IN GENERAL; STEAM ENGINES
- F01L—CYCLICALLY OPERATING VALVES FOR MACHINES OR ENGINES
- F01L9/00—Valve-gear or valve arrangements actuated non-mechanically
- F01L9/20—Valve-gear or valve arrangements actuated non-mechanically by electric means
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T137/00—Fluid handling
- Y10T137/0318—Processes

Landscapes

Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Epidemiology (AREA)
Ophthalmology & Optometry (AREA)
Pulmonology (AREA)
Otolaryngology (AREA)
Mechanical Engineering (AREA)
General Engineering & Computer Science (AREA)
Immunology (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Enzymes And Modification Thereof (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Detergent Compositions (AREA)

MEP-367/08A 1999-11-12 2000-10-14 Solutions containing epinastine MEP36708A (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
DE19954516A DE19954516A1 (de)	1999-11-12	1999-11-12	Epinastin-haltige Lösungen
YUP-336/02A RS50173B (sr)	1999-11-12	2000-10-14	Upotreba epinastina za lečenje alergijskog rinitisa/konjuktivitisa
PCT/EP2000/010122 WO2001035962A1 (fr)	1999-11-12	2000-10-14	Solutions contenant de l'epinastine

Publications (1)

Publication Number	Publication Date
MEP36708A true MEP36708A (en)	2011-02-10

Family

ID=7928843

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MEP-367/08A MEP36708A (en)	1999-11-12	2000-10-14	Solutions containing epinastine

Country Status (40)

Country	Link
US (6)	US20030050303A1 (fr)
EP (1)	EP1231920B1 (fr)
JP (1)	JP2003514021A (fr)
KR (1)	KR100758842B1 (fr)
CN (1)	CN1292752C (fr)
AR (1)	AR026424A1 (fr)
AT (1)	ATE353218T1 (fr)
AU (2)	AU784017B2 (fr)
BG (1)	BG65775B1 (fr)
BR (1)	BR0015477A (fr)
CA (1)	CA2391076C (fr)
CO (1)	CO5251448A1 (fr)
CY (1)	CY1106375T1 (fr)
CZ (1)	CZ302483B6 (fr)
DE (2)	DE19954516A1 (fr)
DK (1)	DK1231920T3 (fr)
EA (1)	EA006937B1 (fr)
EE (1)	EE05395B1 (fr)
ES (1)	ES2281359T3 (fr)
HK (1)	HK1052303B (fr)
HR (1)	HRP20020404B1 (fr)
HU (1)	HU229502B1 (fr)
IL (2)	IL149501A0 (fr)
ME (1)	MEP36708A (fr)
MX (1)	MXPA02004556A (fr)
MY (1)	MY130441A (fr)
NO (1)	NO329417B1 (fr)
NZ (1)	NZ519425A (fr)
PE (1)	PE20010826A1 (fr)
PL (1)	PL198879B1 (fr)
PT (1)	PT1231920E (fr)
RS (1)	RS50173B (fr)
SA (1)	SA01210658B1 (fr)
SI (1)	SI1231920T1 (fr)
SK (1)	SK287343B6 (fr)
TR (1)	TR200201270T2 (fr)
TW (1)	TWI225401B (fr)
UA (1)	UA74563C2 (fr)
WO (1)	WO2001035962A1 (fr)
ZA (1)	ZA200203683B (fr)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE19954516A1 (de) *	1999-11-12	2001-05-17	Boehringer Ingelheim Int	Epinastin-haltige Lösungen
WO2004014353A1 (fr) *	2002-08-02	2004-02-19	Boehringer Ingelheim International Gmbh	Formulations pharmaceutiques a combinaisons d'epinastine, de pseudoephedrine et de methylephedrine
US20040247686A1 (en) *	2003-04-04	2004-12-09	Boehringer Ingelheim International Gmbh	Pharmaceutical compositions comprising epinastine for the treatment of skin diseases
EP1468696A1 (fr) *	2003-04-17	2004-10-20	Boehringer Ingelheim International GmbH	Combinaisons d'épinastine et d'agents antiphlogistiques comme nouvelles compositions pharmaceutiques pour le traitement de maladies de la peau
US20060073172A1 (en) *	2004-10-01	2006-04-06	Schneider L W	Stabilized ophthalmic solution for the treatment of glaucoma and lowering intraocular pressure
CN101217948A (zh) *	2005-07-08	2008-07-09	千寿制药株式会社	包含依匹那丁的透皮吸收眼科制剂
US20080194544A1 (en) *	2007-02-08	2008-08-14	Ramesh Krishnamoorthy	Aqueous formulations of epinastine for treating allergic rhinitis
US7378082B1 (en)	2007-11-05	2008-05-27	Inspire Pharmaceuticals, Inc.	Method for treating allergic rhinitis without adverse effects
WO2008098122A2 (fr) *	2007-02-08	2008-08-14	Inspire Pharmaceuticals, Inc.	Procédé de traitement de rhinite allergique sans effets indésirables
US20120203161A1 (en) *	2009-08-12	2012-08-09	Seros Medical, Llc	Deuterated water and riboflavin solution for extending singlet oxygen lifetimes in treatment of ocular tissue and method of use
TWI544922B (zh)	2011-05-19	2016-08-11	愛爾康研究有限公司	高濃度歐羅派特錠（ｏｌｏｐａｔａｄｉｎｅ）眼用組成物
EP2630952A1 (fr) *	2012-02-23	2013-08-28	Novagali Pharma S.A.	Dispersions d'huile à conservation indépendante comprénant de l'acide borique
BR112015014367B1 (pt) *	2012-12-19	2022-11-22	Novartis Ag	Composição inibidora de lfa-1, método para estabilizar a dita composição e uso da mesma para tratar uma doença ocular
CN104491876A (zh) *	2014-12-23	2015-04-08	中国药科大学	含玻璃酸钠的依匹斯汀滴眼液及其制备方法
ITUB20153950A1 (it) *	2015-09-28	2017-03-28	Tred Srl	Dispositivo nasale in grado di attivare il riflesso rino-palatale per l'igienizzazione rinofaringea
JP6134853B1 (ja) *	2016-10-28	2017-05-24	参天製薬株式会社	エピナスチン含有点眼液
JP6635974B2 (ja) *	2017-04-24	2020-01-29	参天製薬株式会社	エピナスチン含有点眼液
WO2018203424A1 (fr) *	2017-05-01	2018-11-08	参天製薬株式会社	Collyre
JP2019108320A (ja) *	2018-10-31	2019-07-04	参天製薬株式会社	ソフトコンタクトレンズの変質を抑制する眼科用組成物
JP7599838B2 (ja) *	2019-04-10	2024-12-16	参天製薬株式会社	エピナスチン又はその塩を含有する水性医薬組成物
JP6736752B2 (ja) *	2019-12-17	2020-08-05	参天製薬株式会社	エピナスチン含有点眼液
JP7118579B1 (ja)	2020-04-16	2022-08-16	参天製薬株式会社	エピナスチン又はその塩を含有する水性組成物
JP6963651B2 (ja)	2020-04-16	2021-11-10	参天製薬株式会社	エピナスチン又はその塩を含有する水性組成物
JP2020169213A (ja) *	2020-07-15	2020-10-15	参天製薬株式会社	エピナスチン含有点眼液
JP7114668B2 (ja) *	2020-10-08	2022-08-08	参天製薬株式会社	エピナスチン又はその塩を含有する花粉破裂抑制剤
CN115448927A (zh) *	2022-10-20	2022-12-09	重庆瑞泊莱医药科技有限公司	一种氢溴酸依匹斯汀晶型ii及其制备方法

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US151541A (en) *		1874-06-02		Improvement in hay-loaders
US215396A (en) *		1879-05-13		Improvement in loom-temples
US228359A (en) *		1880-06-01		jones
US181478A (en) *		1876-08-22		Improvement in water-wheels
US104017A (en) *		1870-06-07		Improvement in embroidering attachment for sewing-machines
US8632A (en) *		1852-01-06		George hess
US203021A (en) *		1878-04-30		Improvement in side-bar wagons
DE3008944A1 (de) *	1980-03-08	1981-09-24	C.H. Boehringer Sohn, 6507 Ingelheim	Dibenzimidazoazepine, ihre herstellung und verwendung
DE4102148A1 (de) *	1991-01-25	1992-07-30	Boehringer Ingelheim Kg	Verfahren zur herstellung von 3-amino-9,13b-dihydro-1h-dibenz-(c,f)imidazol(1,5-a)azepin-hydrochlorid
US5668133A (en) *	1992-12-09	1997-09-16	Alcon Laboratories, Inc.	Ophthalmic compositions comprising emedastine and methods for their use
UA62917C2 (en) *	1995-06-27	2004-01-15	Berinher Inhelheim Kg	Medicinal composition for generating propellant-free aerosols
DE19542281C2 (de) *	1995-11-14	1997-12-04	Boehringer Ingelheim Kg	Verwendung von Epinastin für die Behandlung der Migräne
US6201011B1 (en) *	1996-08-30	2001-03-13	Kyoto Pharmaceutical Industries, Ltd.	Therapeutic agent for allergic dermatitis
US20030215396A1 (en) *	1999-09-15	2003-11-20	Boehringer Ingelheim Pharma Kg	Method for the production of propellant gas-free aerosols from aqueous medicament preparations
DE19653969A1 (de) *	1996-12-20	1998-06-25	Boehringer Ingelheim Kg	Neue wässrige Arzneimittelzubereitung zur Erzeugung treibgasfreier Aerosole
EP0903151A1 (fr) *	1997-09-22	1999-03-24	ASTA Medica Aktiengesellschaft	Utilisation de combinations comprenant des antihistamines non sédatives et des agonistes alpha-adrenergiques pour le traitement topical du rhinitis/conjunctivitis et des symptomes du rhume et de la grippe
DE19954516A1 (de) *	1999-11-12	2001-05-17	Boehringer Ingelheim Int	Epinastin-haltige Lösungen
MXPA02005007A (es) *	1999-11-18	2004-08-12	Alcon Inc	Uso de un antagonista h1 y un esteroide inocuo para tratar condiciones oculares.
DE19958460A1 (de) *	1999-12-03	2001-06-07	Boehringer Ingelheim Pharma	Verfahren zur Herstellung von Epinastine-Hydrochlorid in der hochschmelzenden Kristallmodifikation
FR2803520B1 (fr) *	2000-01-12	2002-09-20	Ceva Sante Animale	Procede pour augmenter la production d'oeufs et consolider la coquille des oeufs chez les volailles
US20020094345A1 (en) *	2000-10-06	2002-07-18	Sara Abelaira	Pharmaceutical compositions containing epinastine and pseudoephedrine
US20020151541A1 (en) *	2000-10-31	2002-10-17	Michel Pairet	Pharmaceutical compositions containing tiotropium salts and antihistamines and their use
US20020137764A1 (en) *	2000-10-31	2002-09-26	Karin Drechsel	Inhalable formulation of a solution containing a tiotropium salt
DE10119718A1 (de) *	2001-04-21	2002-10-31	Boehringer Ingelheim Pharma	Verfahren zur kontinuierlichen Herstellung inhalierfähiger Arzneistoffe, Vorrichtung zur Durchführung des Verfahrens und nach diesem Verfahren hergestellter Arzneistoff
AU2002305780A1 (en) *	2001-05-29	2002-12-09	Transchip, Inc.	Patent application cmos imager for cellular applications and methods of using such
US20030104017A1 (en) *	2001-10-26	2003-06-05	Boehringer Ingelheim International Gmbh	Epinastine formulation for oral administration
EP1350512A1 (fr) *	2002-04-03	2003-10-08	BOEHRINGER INGELHEIM INTERNATIONAL GmbH	Formulation d'une combinaison d'epinastine, de belladone et de pseudoephedrine
US6863848B2 (en) *	2002-08-30	2005-03-08	Signet Armorlite, Inc.	Methods for preparing composite photochromic ophthalmic lenses
JP2007145316A (ja) *	2005-10-27	2007-06-14	Nissan Motor Co Ltd	遮光装置とサンバイザーとサンルーフユニット

1999
- 1999-11-12 DE DE19954516A patent/DE19954516A1/de not_active Withdrawn
2000
- 2000-10-14 AT AT00972763T patent/ATE353218T1/de active
- 2000-10-14 UA UA2002064760A patent/UA74563C2/uk unknown
- 2000-10-14 HU HU0203773A patent/HU229502B1/hu unknown
- 2000-10-14 EA EA200200492A patent/EA006937B1/ru not_active IP Right Cessation
- 2000-10-14 WO PCT/EP2000/010122 patent/WO2001035962A1/fr not_active Ceased
- 2000-10-14 SK SK830-2002A patent/SK287343B6/sk not_active IP Right Cessation
- 2000-10-14 PT PT00972763T patent/PT1231920E/pt unknown
- 2000-10-14 CN CNB00815547XA patent/CN1292752C/zh not_active Expired - Lifetime
- 2000-10-14 CZ CZ20021956A patent/CZ302483B6/cs not_active IP Right Cessation
- 2000-10-14 BR BR0015477-6A patent/BR0015477A/pt not_active Application Discontinuation
- 2000-10-14 ME MEP-367/08A patent/MEP36708A/xx unknown
- 2000-10-14 HR HR20020404A patent/HRP20020404B1/xx not_active IP Right Cessation
- 2000-10-14 EE EEP200200246A patent/EE05395B1/xx unknown
- 2000-10-14 TR TR2002/01270T patent/TR200201270T2/xx unknown
- 2000-10-14 MX MXPA02004556A patent/MXPA02004556A/es active IP Right Grant
- 2000-10-14 AU AU11381/01A patent/AU784017B2/en not_active Expired
- 2000-10-14 RS YUP-336/02A patent/RS50173B/sr unknown
- 2000-10-14 CA CA002391076A patent/CA2391076C/fr not_active Expired - Lifetime
- 2000-10-14 SI SI200030938T patent/SI1231920T1/sl unknown
- 2000-10-14 HK HK03104651.9A patent/HK1052303B/zh not_active IP Right Cessation
- 2000-10-14 IL IL14950100A patent/IL149501A0/xx unknown
- 2000-10-14 NZ NZ519425A patent/NZ519425A/en not_active IP Right Cessation
- 2000-10-14 EP EP00972763A patent/EP1231920B1/fr not_active Expired - Lifetime
- 2000-10-14 JP JP2001537955A patent/JP2003514021A/ja active Pending
- 2000-10-14 ES ES00972763T patent/ES2281359T3/es not_active Expired - Lifetime
- 2000-10-14 KR KR1020027006058A patent/KR100758842B1/ko not_active Expired - Lifetime
- 2000-10-14 DK DK00972763T patent/DK1231920T3/da active
- 2000-10-14 DE DE50014041T patent/DE50014041D1/de not_active Expired - Lifetime
- 2000-10-14 PL PL364028A patent/PL198879B1/pl unknown
- 2000-11-10 AR ARP000105932A patent/AR026424A1/es unknown
- 2000-11-10 CO CO00085787A patent/CO5251448A1/es not_active Application Discontinuation
- 2000-11-10 PE PE2000001201A patent/PE20010826A1/es not_active Application Discontinuation
- 2000-11-10 MY MYPI20005284A patent/MY130441A/en unknown
- 2000-11-10 TW TW089123815A patent/TWI225401B/zh not_active IP Right Cessation
2001
- 2001-01-20 SA SA01210658A patent/SA01210658B1/ar unknown
2002
- 2002-05-07 IL IL149501A patent/IL149501A/en active IP Right Grant
- 2002-05-08 NO NO20022201A patent/NO329417B1/no not_active IP Right Cessation
- 2002-05-09 BG BG106681A patent/BG65775B1/bg unknown
- 2002-05-09 ZA ZA200203683A patent/ZA200203683B/xx unknown
- 2002-10-15 US US10/271,180 patent/US20030050303A1/en not_active Abandoned
2005
- 2005-08-30 US US11/215,165 patent/US20050288274A1/en not_active Abandoned
2006
- 2006-04-12 AU AU2006201541A patent/AU2006201541A1/en not_active Abandoned
2007
- 2007-03-13 CY CY20071100351T patent/CY1106375T1/el unknown
- 2007-04-12 US US11/734,507 patent/US20070197503A1/en not_active Abandoned
- 2007-04-12 US US11/734,512 patent/US20070185082A1/en not_active Abandoned
- 2007-09-27 US US11/863,008 patent/US7429602B2/en not_active Expired - Lifetime
2009
- 2009-02-27 US US12/394,684 patent/US20090239842A1/en not_active Abandoned

Also Published As

Publication number	Publication date
PL198879B1 (pl)	2008-07-31
NZ519425A (en)	2004-04-30
HUP0203773A3 (en)	2005-01-28
ATE353218T1 (de)	2007-02-15
EA200200492A1 (ru)	2002-10-31
HRP20020404B1 (hr)	2007-08-31
PE20010826A1 (es)	2001-08-20
UA74563C2 (uk)	2006-01-16
EE200200246A (et)	2003-06-16
KR100758842B1 (ko)	2007-09-19
RS50173B (sr)	2009-05-06
EP1231920B1 (fr)	2007-02-07
BG65775B1 (bg)	2009-11-30
NO20022201D0 (no)	2002-05-08
TWI225401B (en)	2004-12-21
US20070197503A1 (en)	2007-08-23
CO5251448A1 (es)	2003-02-28
TR200201270T2 (tr)	2002-12-23
SK287343B6 (sk)	2010-07-07
EE05395B1 (et)	2011-04-15
US20080009476A1 (en)	2008-01-10
BR0015477A (pt)	2002-06-25
BG106681A (en)	2002-12-29
JP2003514021A (ja)	2003-04-15
IL149501A0 (en)	2002-11-10
US20030050303A1 (en)	2003-03-13
PL364028A1 (en)	2004-11-29
CZ20021956A3 (cs)	2002-08-14
HRP20020404A2 (en)	2004-08-31
HUP0203773A2 (hu)	2003-03-28
DE50014041D1 (de)	2007-03-22
ES2281359T3 (es)	2007-10-01
US20070185082A1 (en)	2007-08-09
EA006937B1 (ru)	2006-06-30
ZA200203683B (en)	2003-09-03
MY130441A (en)	2007-06-29
NO329417B1 (no)	2010-10-18
DK1231920T3 (da)	2007-04-10
CY1106375T1 (el)	2011-10-12
YU33602A (sh)	2005-03-15
DE19954516A1 (de)	2001-05-17
HK1052303B (zh)	2007-04-13
MXPA02004556A (es)	2004-09-10
KR20020050273A (ko)	2002-06-26
SK8302002A3 (en)	2002-09-10
CA2391076A1 (fr)	2001-05-25
AR026424A1 (es)	2003-02-12
US7429602B2 (en)	2008-09-30
AU784017B2 (en)	2006-01-12
AU2006201541A1 (en)	2006-05-11
AU1138101A (en)	2001-05-30
HK1052303A1 (en)	2003-09-11
IL149501A (en)	2012-04-30
HU229502B1 (en)	2014-01-28
SI1231920T1 (sl)	2007-06-30
CN1390129A (zh)	2003-01-08
NO20022201L (no)	2002-05-08
US20050288274A1 (en)	2005-12-29
PT1231920E (pt)	2007-03-30
WO2001035962A1 (fr)	2001-05-25
CZ302483B6 (cs)	2011-06-08
CA2391076C (fr)	2008-06-17
CN1292752C (zh)	2007-01-03
SA01210658B1 (ar)	2006-11-05
US20090239842A1 (en)	2009-09-24
EP1231920A1 (fr)	2002-08-21

Publication	Publication Date	Title
MEP36708A (en)	2011-02-10	Solutions containing epinastine
BR9916111A (pt)	2001-09-04	Derivados de fenilglicina
SV2002000356A (es)	2002-06-07	Nuevos derivados de piperazina ref. pc10770aixn/bb
NO992617L (no)	1999-06-01	Sulfinsyrederivater, deres fremstilling og anvendelse
PT1282663E (pt)	2005-11-30	Gel constituido por um poli-alfa-1,4-glucano e amido
HRP20020198B1 (hr)	2011-02-28	Formulacija moksifloksacina i kuhinjske soli
BR9713338A (pt)	2000-05-09	Benzonaftiridinas como terapêuticos brÈnquicos.
NO20032788L (no)	2003-07-07	Modafinil-forbindelse og cyklodekstrinblandinger
ATE283045T1 (de)	2004-12-15	Stabile ascorbinsäure enthaltende zubereitung zur topischen anwendung
MX9405434A (es)	1995-01-31	Composicion de peroxido de hidrogeno.
PL357132A1 (en)	2004-07-12	Stable, nasally, orally or sublingually applicable pharmaceutical preparation
DOP2001000268A (es)	2002-05-30	Derivados puente de piperazina
IT1318535B1 (it)	2003-08-27	Processo per la preparazione di sali farmaceuticamente accettabili di(ss,rs)-s-adenosil-l-metionina.
IS6654A (is)	2002-12-11	Stöðugt gabapentín með pH innan stýrðra marka
GB2387101A (en)	2003-10-08	Compositions containing creatine and creatinine
ATE295165T1 (de)	2005-05-15	Mittel zur adjuvanten therapie von demenzen enthaltend alpha-liponsäure
MEP36808A (en)	2011-02-10	Ambroxol-containing lozenge
HRP20010764B1 (hr)	2011-01-31	Oralna otopina s prukalopridom
BR0113650A (pt)	2004-02-10	N-(3,5-dicloro-2-metoxifenil)-4-metóxi-3-piperazina-1-il a-benzenossulfonamida
BRPI0415034A (pt)	2006-12-12	derivados de aminopiridina como inibidores de não-sintase induzìveis
BR0113783B1 (pt)	2013-11-12	Composição aquosa
SV2002000302A (es)	2002-07-16	Nuevos derivados de amidas heterociclicas ref. pc 10561/20140/bb
DE60304061D1 (de)	2006-05-11	Radsatzführung
TR200202439T2 (tr)	2003-02-21	Sodyum hidrojen değiştirici tip 1 önleyici (NHE-1)
HN2000000090A (es)	2001-04-20	Sal difosfato de un derivado de 4sustituido-9-desoxo-9a-aza-9a-homoeritromicina y su composicion farmaceutica.